Cardinal Health Launches Next-Generation Compression System

Strategic Insights -

Cardinal Health has announced the international launch of its Kendall SCD SmartFlow[TM] Compression System, a next-generation compression system designed to help prevent venous thromboembolism (VTE) events, enhance blood circulation, and treat pain and swelling related to venous stasis. The system features clinically proven technology that delivers customized, intermittent pneumatic compression (IPC) to increase blood flow in at-risk patients. With the ability to detect and adjust to a patient's unique vascular refill time, the Kendall SCD SmartFlow[TM] System is designed to provide consistent, effective, and reliable compression therapy.

Key Takeaways:

  • The Kendall SCD SmartFlow[TM] Compression System is designed to help prevent VTE events, enhance blood circulation, and treat pain and swelling related to venous stasis.
  • The system features clinically proven technology that delivers customized, intermittent pneumatic compression (IPC) to increase blood flow in at-risk patients.
  • The VRD technology adjusts and customizes compression cycles to match a patient's unique vascular refill time, helping the patient receive more compression cycles over time and ultimately reducing stasis.
  • The system has a proprietary Patient Sensing[TM] Technology that automatically detects if compression therapy is being applied and will activate an alert if the system does not detect a patient present or correct use of the sleeves on the patient's legs.
  • The Therapy Tracker feature tracks the duration of compression therapy to help hospitals maintain compliance and enhance patient safety.
  • The system is now available in Europe, Australia, New Zealand, Brazil, and Korea, with plans to expand to other markets across the Middle East, Africa, Asia, and Latin America.
  • The Kendall SCD SmartFlow[TM] Compression System is designed to help streamline clinical workflows, allowing healthcare professionals to dedicate more time to direct patient care.
  • Frederic LeRoy, VP of International Marketing, stated that the new system addresses symptoms that can significantly impact patients with compromised blood flow.

Statistics:

  • The Kendall SCD SmartFlow[TM] System is designed to move more blood per hour than uniform compression.
  • The system is capable of delivering over 400 cycles of compression therapy per hour.
  • VTE events are a significant concern in hospitals, with up to 60% of patients being at risk.
  • The use of compression therapy can reduce VTE events by up to 50%.
  • The Kendall SCD SmartFlow[TM] System is designed to help reduce hospital acquired venous thromboembolism (HAVTE) events.

Sources:

  • NewsRx, Medical Devices & Surgical Technology Week
  • Cardinal Health press release, October 26, 2025.